LiverMultiScan® could be an alternative to liver biopsy for NASH clinical trials.
February 4, 2021
UVA Health First Hospital in the State to Offer LiverMultiScan for Non-Invasive Assessment of Liver Disease
February 2, 2021
Perspectum launches study to improve outcomes for patients with liver cancer
January 14, 2021
World’s First Integrated Imaging Service for Long Covid approved by UK’s MHRA
FDA awards funding to Perspectum and physicians at Massachusetts General Hospital to accelerate development of imaging biomarkers as drug development tools in liver disease
December 14, 2020
Perspectum’s RADIcAL1 trial - addressing the health economic burden of invasive diagnostics for NAFLD and NASH
December 9, 2020
Hepatica – new tool informs surgeons about previously undiagnosed background liver disease, helping to improve surgical decision-making in liver cancer care
December 2, 2020
Post-conference Q&A - AASLD: The Digital Liver Meeting Experience
Perspectum presents new data, addressing key challenges of smart imaging
November 29, 2020
